Pioneering efforts to address a common IV therapy complication brought into focus at upcoming association programs

HAMPTON, Va., February 6, 2019 – Several nursing associations have incorporated ivWatch representatives and customers in educational programming to present the latest advances in using sensor technology to identify peripheral IV infiltration/extravasation events earlier than ever before to reduce patient injury.

The Infusion Nurses Society (INS) ‘Talking in Vein’ podcast series is part of the association’s learning center and a forum to discuss infusion-related topics with clinical experts, patient advocates and industry leaders. Launching today is a show with guests Mary Alexander MA, RN, CRNI, CAE, FAAN, CEO of Infusion Nurses Society and Gary Warren, president and CEO of ivWatch. The podcast, “Infiltration: Not What We Thought It Was,” reviews misconceptions about IV failure. During the show Warren discusses how technology can impact and provide better clinical outcomes but asserts it should not replace clinical critical thinking.

In her final remarks, Alexander concludes, “It’s helpful that devices such as ivWatch will warn us of an impending infiltration, however I can’t stress enough the importance of nursing assessment and patient feedback. I do believe there is a nice marriage between practice and technology, and I think it’s important that we’ve got the right balance with the two.”

The discussion showcases the willingness of professional associations and medical device manufacturers to work together to review the real-world implications of novel technology. Additional upcoming events where experts will share their work combating the potential for injury from peripheral IV infiltration/extravasation include:

  • On February 13, Gregory Schears, MD, a pediatric intensivist and anesthesiologist at the Mayo Clinic will facilitate a live webinar session “Short Peripheral Catheter Infiltration: Minimizing Risks to Improve Outcomes,” hosted by the Infusion Nurses Society.
  • On April 25, vascular access leaders from Cincinnati Children’s Hospital Medical Center, Sylvia Rineair MSHA, BSN, RN, VA-BC and Darcy Doellman MSN, RN, CRNI, VA-BC, will speak at the 2019 American Nurses Association (ANA) Quality and Innovation Conference. They will discuss a quality improvement project including clinical studies and deployment of ivWatch technology to reduce patient harm from peripheral IV complications during the concurrent session “Improving the Safety of Peripheral IVs with Novel Technology.” 
  • On April 26, ivWatch Chief Nursing Officer (CNO), Susan Brown joins Jamie Carter BSN, RN, patient care services director at Children’s Hospital of the Kings Daughters at the Society of Pediatric Nurses (SPN) 29th Annual Conference. The joint podium presentation will review how the institution reduced severe peripheral IV infiltration/extravasation events through nurse education and ivWatch technology.

Through educational initiatives like these along with sponsorship of the platform myIV.com, ivWatch showcases continued commitment to improving patient safety and outcomes. To learn more about ivWatch and upcoming event participation, visit www.ivWatch.com/events/.

About ivWatch:
ivWatch, LLC is a medical biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians are able to leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative monitored IV solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch or Facebook @ivWatchLLC, or visit www.ivwatch.com.

ivWatch is pleased to sponsor the work of myIV.com, an online resource dedicated to empowering visitors with information on all things IV, simplified.

MEDIA CONTACT: Amara Betoney, amara.betoney@ivwatch.com, Direct (757) 224-2606, Office (855) 489-2824 x7007, Mobile (757) 660-4949

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest